Overview

Phase 0 Study of FL-101 in Non-Metastatic MIBC

Status:
Not yet recruiting
Trial end date:
2022-12-28
Target enrollment:
Participant gender:
Summary
A pilot window of opportunity study of FL-101 in patients with non-metastatic MIBC who are eligible for radical cystectomy (RC) but are ineligible for, or decline, cisplatin-based neoadjuvant therapy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Flame Biosciences